- Report
- December 2025
- 52 Pages
Global
From €6700EUR$7,500USD£5,730GBP
- Report
- December 2025
Global
From €6700EUR$7,500USD£5,730GBP
- Report
- September 2025
- 126 Pages
Europe
From €5355EUR$5,995USD£4,580GBP
- Report
- September 2025
- 100 Pages
North America
From €5355EUR$5,995USD£4,580GBP
- Report
- September 2025
- 127 Pages
Asia Pacific
From €5355EUR$5,995USD£4,580GBP
- Report
- April 2023
- 75 Pages
Global
From €3350EUR$3,750USD£2,865GBP
- Report
- July 2020
- 156 Pages
Global
From €4422EUR$4,950USD£3,782GBP
- Report
- January 2025
- 180 Pages
Global
From €5315EUR$5,950USD£4,546GBP
- Report
- October 2024
- 100 Pages
Global
From €5315EUR$5,950USD£4,546GBP
- Report
- June 2023
- 180 Pages
Global
From €5315EUR$5,950USD£4,546GBP
- Report
- August 2025
- 187 Pages
Global
From €3167EUR$3,545USD£2,708GBP
€3519EUR$3,939USD£3,009GBP
- Report
- August 2025
- 192 Pages
Global
From €3167EUR$3,545USD£2,708GBP
€3519EUR$3,939USD£3,009GBP
- Report
- August 2025
- 182 Pages
Global
From €3167EUR$3,545USD£2,708GBP
€3519EUR$3,939USD£3,009GBP
- Report
- August 2025
- 187 Pages
Global
From €3167EUR$3,545USD£2,708GBP
€3519EUR$3,939USD£3,009GBP
- Report
- October 2024
- 200 Pages
Global
From €3350EUR$3,750USD£2,865GBP
- Report
- January 2024
- 200 Pages
Global
From €3707EUR$4,150USD£3,171GBP
- Report
- August 2023
- 145 Pages
Global
From €2814EUR$3,150USD£2,407GBP
- Report
- July 2023
- 145 Pages
Global
From €2814EUR$3,150USD£2,407GBP
- Report
- June 2024
- 200 Pages
Global
From €7102EUR$7,950USD£6,074GBP
- Report
- July 2024
- 100 Pages
Global
From €3350EUR$3,750USD£2,865GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more